BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23775934)

  • 1. Neurodevelopmental disorders and genetic testing: current approaches and future advances.
    Sherr EH; Michelson DJ; Shevell MI; Moeschler JB; Gropman AL; Ashwal S
    Ann Neurol; 2013 Aug; 74(2):164-70. PubMed ID: 23775934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics and the investigation of developmental delay/intellectual disability.
    Srour M; Shevell M
    Arch Dis Child; 2014 Apr; 99(4):386-9. PubMed ID: 24344174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing scenario for intellectual disability, developmental delay, and autism challenged.
    Am J Med Genet A; 2018 Jan; 176(1):7-8. PubMed ID: 29232062
    [No Abstract]   [Full Text] [Related]  

  • 4. Updates in the genetic evaluation of the child with global developmental delay or intellectual disability.
    Flore LA; Milunsky JM
    Semin Pediatr Neurol; 2012 Dec; 19(4):173-80. PubMed ID: 23245550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical approach to developmental delay and intellectual disability.
    Vasudevan P; Suri M
    Clin Med (Lond); 2017 Dec; 17(6):558-561. PubMed ID: 29196358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-generation sequencing approaches and challenges in the diagnosis of developmental anomalies and intellectual disability.
    Bruel AL; Vitobello A; Tran Mau-Them F; Nambot S; Sorlin A; Denommé-Pichon AS; Delanne J; Moutton S; Callier P; Duffourd Y; Philippe C; Faivre L; Thauvin-Robinet C
    Clin Genet; 2020 Nov; 98(5):433-444. PubMed ID: 32335911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features.
    Battaglia A; Doccini V; Bernardini L; Novelli A; Loddo S; Capalbo A; Filippi T; Carey JC
    Eur J Paediatr Neurol; 2013 Nov; 17(6):589-99. PubMed ID: 23711909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Special report: aCGH for the genetic evaluation of patients with developmental delay/mental retardation or autism spectrum disorder.
    Technol Eval Cent Assess Program Exec Summ; 2009 Apr; 23(10):1-5. PubMed ID: 19824216
    [No Abstract]   [Full Text] [Related]  

  • 9. [Multiplex Ligation - dependent Probe Amplification (MLPA) as a screening test in children with developmental defects and intellectual disability of unknown etiology].
    Laczmańska I; Jakubiak A; Slęzak R; Pesz K; Stembalska A; Laczmański L; Sąsiadek MM; Smigiel R
    Med Wieku Rozwoj; 2011; 15(2):132-9. PubMed ID: 22002044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene hunt is on for mental disability.
    Callaway E
    Nature; 2012 Apr; 484(7394):302-3. PubMed ID: 22517145
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnostic Yield of Intellectual Disability Gene Panels.
    Pekeles H; Accogli A; Boudrahem-Addour N; Russell L; Parente F; Srour M
    Pediatr Neurol; 2019 Mar; 92():32-36. PubMed ID: 30581057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical genetics diagnostic evaluation of the child with global developmental delay or intellectual disability.
    Moeschler JB
    Curr Opin Neurol; 2008 Apr; 21(2):117-22. PubMed ID: 18317267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic approach with genetic tests for global developmental delay and/or intellectual disability: Single tertiary center experience.
    Han JY; Jang W; Park J; Kim M; Kim Y; Lee IG
    Ann Hum Genet; 2019 May; 83(3):115-123. PubMed ID: 30402882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosomal Microarray Analysis Has a Poor Diagnostic Yield in Children with Developmental Delay/Intellectual Disability When Concurrent Cerebellar Anomalies Are Present.
    Ciaccio C; Pantaleoni C; Bulgheroni S; Sciacca F; D'Arrigo S
    Cerebellum; 2020 Oct; 19(5):629-635. PubMed ID: 32472476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Neurogenetic Developmental Conditions: From 2016 into the Future.
    van Karnebeek CD; Bowden K; Berry-Kravis E
    Pediatr Neurol; 2016 Dec; 65():1-13. PubMed ID: 27697313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetics, copy number variation, and other molecular mechanisms underlying neurodevelopmental disabilities: new insights and diagnostic approaches.
    Gropman AL; Batshaw ML
    J Dev Behav Pediatr; 2010 Sep; 31(7):582-91. PubMed ID: 20814257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global developmental delay and intellectual disability in the era of genomics: Diagnosis and challenges in resource limited areas.
    Masri AT; Oweis L; Ali M; Hamamy H
    Clin Neurol Neurosurg; 2023 Jul; 230():107799. PubMed ID: 37236004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on the investigation of children with delayed development.
    Silove N; Collins F; Ellaway C
    J Paediatr Child Health; 2013 Jul; 49(7):519-25. PubMed ID: 23600797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal microarray testing influences medical management.
    Coulter ME; Miller DT; Harris DJ; Hawley P; Picker J; Roberts AE; Sobeih MM; Irons M
    Genet Med; 2011 Sep; 13(9):770-6. PubMed ID: 21716121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive diagnostic value for the clinical features accompanying intellectual disability in children with pathogenic copy number variations: a multivariate analysis.
    Caramaschi E; Stanghellini I; Magini P; Giuffrida MG; Scullin S; Giuva T; Bergonzini P; Guerra A; Paolucci P; Percesepe A
    Ital J Pediatr; 2014 Apr; 40():39. PubMed ID: 24775911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.